Ex-Allergan CEO Saunders pops up again in ‘blank cheque’ company

Pharma Phorum

Prior to the $63 billion takeover by AbbVie, Allergan’s biggest product was botulinum toxin product Botox, best known as a wrinkle and migraine treatment, and that headed a sizeable medical aesthetics portfolio at the company which also included dermal filler products like Juvederm.

Botox 70

Emotional empathy is driving brand equity

Pharma Phorum

We see the dedication of healthcare workers – or of the shelf-filler in our local store – and we are moved to thank them and to make our own contribution. How the COVID-19 pandemic is forging pharmaceutical brands into better shape.